The role of haematological parameters in patients with COVID-19 and influenza virus infection

Autor: Hurrem Bodur, Sumeyye Kazancioglu, Bahadır Orkun Ozbay, Aliye Bastug, Nizamettin Kemirtlek
Rok vydání: 2020
Předmět:
Adult
Male
0301 basic medicine
medicine.medical_specialty
Adolescent
Coronavirus disease 2019 (COVID-19)
Epidemiology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
red blood cell
Disease
medicine.disease_cause
Gastroenterology
Virus
Young Adult
03 medical and health sciences
0302 clinical medicine
neutrophil-to-lymphocyte ratio
Internal medicine
Influenza
Human

medicine
Humans
Platelet
030212 general & internal medicine
Neutrophil to lymphocyte ratio
Aged
Coronavirus
Aged
80 and over

Original Paper
SARS-CoV-2
business.industry
fungi
COVID-19
Middle Aged
platelet-to-lymphocyte ratio
Blood Cell Count
body regions
Red blood cell
030104 developmental biology
Infectious Diseases
medicine.anatomical_structure
Area Under Curve
Case-Control Studies
delta neutrophil index
Female
influenza
business
Zdroj: Epidemiology and Infection
ISSN: 1469-4409
0950-2688
Popis: SARS-CoV-2, the causative agent of coronavirus disease 19 (COVID-19), was identified in Wuhan, China. Since then, the novel coronavirus started to be compared to influenza. The haematological parameters and inflammatory indexes are associated with severe illness in COVID-19 patients. In this study, the laboratory data of 120 COVID-19 patients, 100 influenza patients and 61 healthy controls were evaluated. Lower lymphocytes, eosinophils, basophils, platelets and higher delta neutrophil index (DNI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were found in COVID-19 and influenza groups compared to healthy controls. The eosinophils, lymphocytes and PLR made the highest contribution to differentiate COVID-19 patients from healthy controls (area under the curves (AUCs): 0.819, 0.817 and 0.716, respectively; P-value is P < 0.0001). Higher leucocytes, neutrophils, DNI, NLR, PLR and lower lymphocytes, red blood cells, haemoglobin, haematocrit levels were found in severe patients at the end of treatment. Nonsevere patients showed an upward trend for lymphocytes, eosinophils and platelets, and a downward trend for neutrophils, DNI, NLR and PLR. However, there was an increasing trend for eosinophils, platelets and PLR in severe patients. In conclusion, NLR and PLR can be used as biomarkers to distinguish COVID-19 patients from healthy people and to predict the severity of COVID-19. The increasing value of PLR during follow-up may be more useful compared to NLR to predict the disease severity.
Databáze: OpenAIRE